Your session is about to expire
← Back to Search
Non-Operative Management Approaches for Urinary Incontinence
N/A
Waitlist Available
Led By Goutham Rao, MD
Research Sponsored by Adonis Hijaz, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
≥ 18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months (waves 1 and 2)
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing different approaches to improve diagnosis and non-operative management of urinary incontinence in women.
Who is the study for?
This trial is for women over 18 who are experiencing urinary incontinence and have visited the University Hospitals Cleveland Primary Care Institute. Participants should score at least 1 on a specific questionnaire about incontinence.
What is being tested?
The EMPOWER study aims to enhance the diagnosis and non-surgical treatment of urinary incontinence among women, using patient education, nurse-led guidance, and a ChatBot to provide support.
What are the potential side effects?
Since this trial focuses on educational interventions rather than medications or surgeries, side effects are not typical but may include discomfort from discussing personal health issues.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months (waves 1 and 2)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months (waves 1 and 2)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in patients' UI symptoms as measured by International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF)
Urinary Incontinence
Secondary study objectives
Change in impact of UI on patients' quality of life as measured by the ICIQ-LUTSqol
Change in overactive bladder symptom severity as measured by the OABSS
Change in patient empowerment as measured by a patient survey
+10 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: Arm 3Experimental Treatment3 Interventions
Patient Education + Nurse Navigation + ChatBot
Group II: Arm 2Experimental Treatment2 Interventions
Patient Education + Nurse Navigation
Group III: Arm 1Experimental Treatment1 Intervention
Patient Education
Find a Location
Who is running the clinical trial?
Adonis Hijaz, MDLead Sponsor
Goutham Rao, MDPrincipal InvestigatorUniversity Hospitals Cleveland Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Not applicable.I am 18 years old or older.I am a woman who has seen a doctor at UH Cleveland's Primary Care Institute.You score 1 or higher on a questionnaire about urinary incontinence.
Research Study Groups:
This trial has the following groups:- Group 1: Arm 1
- Group 2: Arm 2
- Group 3: Arm 3
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.